单次伽玛刀放射外科治疗松果体区脑膜瘤:44例回顾性单中心队列
本研究回顾性分析44例接受单次伽玛刀放射外科治疗的松果体区脑膜瘤成人患者,中位影像随访88个月。结果显示局部控制率2年100%、5年97.1%、10年86.3%,进展生存率分别为100%、94.1%、72.6%,放射性不良反应发生率6.8%且无永久后遗症。结论认为单次伽玛刀可提供持久肿瘤控制且毒性低,支持其作为特定患者的主要治疗策略。
要点
- 单次伽玛刀治疗松果体区脑膜瘤10年局部控制率达86.3%。
- 放射性不良反应发生率6.8%,均无永久后遗症。
- 所有患者KPS稳定或改善,支持作为特定患者主要治疗策略。
核心结论
- 单次伽玛刀放射外科治疗松果体区脑膜瘤可获得持久肿瘤控制、低毒性和神经功能保留,支持其作为特定患者的主要治疗策略。
研究设计与样本
- 单中心回顾性队列研究,纳入44例连续成人松果体区脑膜瘤患者,均接受单次伽玛刀放射外科治疗;诊断基于既往手术后组织病理学或预设MRI标准并经神经影像共识复核。
主要发现
- 中位临床随访90个月、影像随访88个月;末次影像随访时局部控制42/44例(95.5%),其中退缩13例(29.5%)、稳定29例(65.9%)。
- Kaplan-Meier局部控制率2年100%、5年97.1%、10年86.3%;无进展生存率2年100%、5年94.1%、10年72.6%。
- 放射性不良反应发生于3例(6.8%),均无永久后遗症;所有患者KPS稳定或改善。
关键数值与推荐
- 肿瘤体积缩小≥20%定义为退缩,变化<20%定义为稳定,增大≥20%定义为进展。
临床怎么用
- 单次伽玛刀可作为经选择的松果体区脑膜瘤患者的主要治疗策略,并需长期影像随访监测局部控制。
局限性
- 回顾性单中心设计,样本量44例,辅助治疗结果仅为初步且需更大队列验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the long-term efficacy and safety of single-fraction Gamma Knife radiosurgery (GKRS) for pineal region meningiomas (PMs) and to clarify its role as both a primary and adjuvant treatment strategy for this anatomically challenging tumor location. METHODS: This single-center retrospective cohort study included 44 consecutive adults with PMs treated with single-fraction GKRS. Diagnosis was established histopathologically after prior surgery or by predefined MRI criteria with consensus neuroradiological review. Tumor response was assessed volumetrically on serial contrast-enhanced MRI, with regression, stability, and progression defined as ≥ 20% decrease, < 20% change, and ≥ 20% increase in tumor volume, respectively. Local control (LC), progression-free survival (PFS), overall survival (OS), adverse radiation effects (AREs), and Karnofsky Performance Scale (KPS) outcomes were analyzed. RESULTS: Median clinical and radiological follow-up were 90 and 88 months, respectively. At last radiological follow-up, LC was achieved in 42 of 44 patients (95.5%), including regression in 13 (29.5%) and stability in 29 (65.9%). Kaplan-Meier LC rates were 100% at 2 years, 97.1% at 5 years, and 86.3% at 10 years. PFS rates were 100%, 94.1%, and 72.6% at 2, 5, and 10 years, respectively. AREs occurred in 3 patients (6.8%), all without permanent sequelae. KPS remained stable or improved in all patients. CONCLUSION: Single-fraction GKRS provides durable tumor control with low toxicity and preserved neurological function in PMs, supporting its use as a primary treatment strategy in selected patients. Preliminary adjuvant results are encouraging but require validation in larger cohorts.
引用
- Duzkalir AH, Yildirim DC, Askeroglu MO, et al. Single-fraction Gamma Knife radiosurgery for pineal region meningiomas: a retrospective single-center cohort of 44 patients. J Neurooncol. 2026. PMID: 41981224. doi:10.1007/s11060-026-05566-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。